UNITED THERAPEUTICS Corp (NASDAQ:UTHR) filed a Form 8-K with the Securities and Exchange Commission on January 22, 2026, disclosing a material event.
UNITED THERAPEUTICS Corp's stock currently trades at $472.06 with a market capitalization of $21.8B. The Healthcare company's stock moved following the disclosure.


